| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 16 Oct 2025 | 13 Oct 2025 |
| Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2025 inter alia to consider and approve Intimitation of Board Meeting Schedule to be held on 16th October 2025 to discuss the following item 1. To consider the appointment of CA. Yash Jain as internal auditor of the Company. 2. To consider the appointment of Mr. Yogesh Prakash Supekar as Additional Non-Executive Director of the Company. 3. To consider the Appointment of Mr. Rishi Upadhaya as Company Secretary and Compliance officer of the Company. 4. Other agenda items. | ||
| Board Meeting | 25 Aug 2025 | 21 Aug 2025 |
| Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2025 inter alia to consider and approve 1. To convene the 6th Annual General Meeting of the Company and approve the draft notice and explanatory statement; 2. To consider and approve the draft report of the Board together with the Management Discussion and Analysis Report forming part of the Annual report for the year ended 31st March 2025; 3. Any other incidental matters. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.